Aethlon Medical Inc (NASDAQ:AEMD) has a beta value of 1.72 and has seen 0.84 million shares traded in the recent trading session. The company, currently valued at $2.96M, closed the recent trade at $1.14 per share which meant it lost -$0.01 on the day or -0.43% during that session. The AEMD stock price is -640.35% off its 52-week high price of $8.44 and 3.51% above the 52-week low of $1.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.74 million shares traded. The 3-month trading volume is 216.77K shares.
The consensus among analysts is that Aethlon Medical Inc (AEMD) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Aethlon Medical Inc (NASDAQ:AEMD) trade information
Sporting -0.43% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the AEMD stock price touched $1.14 or saw a rise of 27.85%. Year-to-date, Aethlon Medical Inc shares have moved -67.05%, while the 5-day performance has seen it change -3.78%. Over the past 30 days, the shares of Aethlon Medical Inc (NASDAQ:AEMD) have changed -41.88%. Short interest in the company has seen 28330.0 shares shorted with days to cover at 0.66.
Aethlon Medical Inc (AEMD) estimates and forecasts
The company’s shares have lost -78.54% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 43.53% over the past 5 years. Earnings growth for 2025 is a modest 76.04% while over the next 5 years, the company’s earnings are expected to increase by 60.97%.
AEMD Dividends
Aethlon Medical Inc is expected to release its next earnings report on 2025-Jun-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aethlon Medical Inc (NASDAQ:AEMD)’s Major holders
Insiders own 0.94% of the company shares, while shares held by institutions stand at 21.15% with a share float percentage of 21.35%. Investors are also buoyed by the number of investors in a company, with Aethlon Medical Inc having a total of 22.0 institutions that hold shares in the company. The top two institutional holders are SUSQUEHANNA INTERNATIONAL GROUP, LLP with over 36652.0 shares worth more than $18278.0. As of 2024-06-30, SUSQUEHANNA INTERNATIONAL GROUP, LLP held 0.4915% of shares outstanding.
The other major institutional holder is TWO SIGMA SECURITIES, LLC, with the holding of over 34544.0 shares as of 2024-06-30. The firm’s total holdings are worth over $17227.0 and represent 0.4632% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of May 31, 2025 , the former fund manager holds about 0.40% shares in the company for having 10.23 shares of worth $11833.0 while later fund manager owns 2.65 shares of worth $3067.0 as of Mar 31, 2025 , which makes it owner of about 0.10% of company’s outstanding stock.
